The efficiency of (18)F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancer

PURPOSE: Investigate whether (18)F-FDG PET-CT has the potential to predict the major pathologic response (MPR) to neoadjuvant sintilimab in resectable NSCLC patients, and the potential of sifting patients who probably benefit from immunotherapy. METHODS: Treatment-naive patients with resectable NSCL...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Nucl Med Mol Imaging
Main Authors: Tao, Xiuli, Li, Ning, Wu, Ning, He, Jie, Ying, Jianming, Gao, Shugeng, Wang, Shuhang, Wang, Jie, Wang, Zhijie, Ling, Yun, Tang, Wei, Zhang, Zewei
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7101299/
https://ncbi.nlm.nih.gov/pubmed/32043180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-020-04711-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados